Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.

UNLABELLED Abstract Background and Purpose: Topical chemotherapy for urothelial cancer is dependent on adequate contact time of the chemotherapeutic agent with the urothelium. To date, there has not been a reliable method of maintaining this contact for renal or ureteral urothelial carcinoma. We evaluated the safety and feasibility of using a reverse thermosensitive polymer to improve dwell times of mitomycin C (MMC) in the upper tract. MATERIALS AND METHODS Using a porcine model, four animals were treated ureteroscopically with both upper urinary tracts receiving MMC mixed with iodinated contrast. One additional animal received MMC percutaneously. The treatment side had ureteral outflow blocked with a reverse thermosensitive polymer plug. MMC dwell time was monitored fluoroscopically and intrarenal pressures measured. Two animals were euthanized immediately, and three animals were euthanized 5 days afterward. RESULTS In control kidneys, drainage occurred at a mean of 5.3±0.58 minutes. Intrarenal pressures stayed fairly stable: 9.7±14.0 cm H20. In treatment kidneys, dwell time was extended to 60 minutes, when the polymer was washed out. Intrarenal pressures in the treatment kidneys peaked at 75.0±14.7 cm H20 and reached steady state at 60 cm H20. Pressures normalized after washout of the polymer with cool saline. Average washout time was 11.8±9.6 minutes. No histopathologic differences were seen between the control and treatment kidneys, or with immediate compared with delayed euthanasia. CONCLUSIONS A reverse thermosensitive polymer can retain MMC in the upper urinary tract and appears to be safe from our examination of intrarenal pressures and histopathology. This technique may improve the efficacy of topical chemotherapy in the management of upper tract urothelial carcinoma.

[1]  T. Kessler,et al.  Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? , 2011, European urology.

[2]  M. Elhilali,et al.  The use of a novel reverse thermosensitive polymer to prevent ureteral stone retropulsion during intracorporeal lithotripsy: a randomized, controlled trial. , 2010, Journal of Urology.

[3]  S. Landas,et al.  Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model. , 2008, Anticancer research.

[4]  W. Mcdougal,et al.  Preventing migration of stones during fragmentation with thermosensitive polymer. , 2007, Journal of endourology.

[5]  G. Preminger,et al.  Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. , 2004, Journal of endourology.

[6]  J. Huguet,et al.  Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. , 2004, The Journal of urology.

[7]  R. Sylvester,et al.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.

[8]  G. Chen,et al.  Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. , 2000, The Journal of urology.

[9]  M. Blute,et al.  Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. , 1999, Urology.

[10]  Peter Clark,et al.  13-year experience with percutaneous management of upper tract transitional cell carcinoma. , 1999 .

[11]  F. Keeley,et al.  Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. , 1997, The Journal of urology.

[12]  N. Bodsworth,et al.  Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. , 1997, Genitourinary medicine.

[13]  M. Parmar,et al.  The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. , 1996, The Journal of urology.

[14]  T. A. Hatton,et al.  Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling , 1995 .

[15]  J. Eastham,et al.  Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. , 1993, The Journal of urology.

[16]  W. Whitmore,et al.  Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report , 1985, Cancer.

[17]  G. Fuchs,et al.  New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. , 1998, The Journal of urology.

[18]  R. Kohler Investigations on backflow in retrograde pyelography; a roentgenological and clinical study. , 1953, Acta radiologica.

[19]  E. Berven Hugo Ahlbom: in memoriam. , 1953 .